Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johanna Flach

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Mutation Research|October 29, 2017
Replication stress in hematopoietic stem cells in mouse and manJohanna Flach, Michael Milyavsky
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 10, 2020
Clonal Evolution after Allogeneic Hematopoietic Stem Cell Transplantation: The Case of MyelofibrosisMaximilian Christopeit, Anita Badbaran, Malik Alawi, et al.
Critical Reviews in Oncology/Hematology|May 24, 2020
Current concepts and future directions for hemato-oncologic diagnosticsJohanna Flach, Evgenii Shumilov, Raphael Joncourt, et al.
Annals of Hematology|April 8, 2020
Separase activity distribution can be a marker of major molecular response and proliferation of CD34<sup>+</sup> cells in TKI-treated chronic myeloid leukemia patientsBirgit Spiess, Helga Kleiner, Johanna Flach, et al.
The Journal of Experimental Medicine|February 5, 2014
Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferonsEric M Pietras, Ranjani Lakshminarasimhan, Jose-Marc Techner, et al.
Blood Reviews|May 6, 2018
Current status and trends in the diagnostics of AML and MDSEvgenii Shumilov, Johanna Flach, Alexander Kohlmann, et al.
Nature|February 8, 2013
FOXO3A directs a protective autophagy program in haematopoietic stem cellsMatthew R Warr, Mikhail Binnewies, Johanna Flach, et al.
Critical Reviews in Oncology/Hematology|May 16, 2018
Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors: Diagnostic challenges in the era of high-throughput sequencing in hemato-oncologyEvgenii Shumilov, Johanna Flach, Thomas Pabst, et al.
Hematological Oncology|April 20, 2020
Clinical potential of introducing next-generation sequencing in patients at relapse of acute myeloid leukemiaJohanna Flach, Evgenii Shumilov, Gertrud Wiedemann, et al.
Blood Cancer Journal|November 14, 2018
Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine useUlrike Bacher, Evgenii Shumilov, Johanna Flach, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Mutation Research|October 29, 2017
Replication stress in hematopoietic stem cells in mouse and manJohanna Flach, Michael Milyavsky
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 10, 2020
Clonal Evolution after Allogeneic Hematopoietic Stem Cell Transplantation: The Case of MyelofibrosisMaximilian Christopeit, Anita Badbaran, Malik Alawi, et al.
Critical Reviews in Oncology/Hematology|May 24, 2020
Current concepts and future directions for hemato-oncologic diagnosticsJohanna Flach, Evgenii Shumilov, Raphael Joncourt, et al.
Annals of Hematology|April 8, 2020
Separase activity distribution can be a marker of major molecular response and proliferation of CD34<sup>+</sup> cells in TKI-treated chronic myeloid leukemia patientsBirgit Spiess, Helga Kleiner, Johanna Flach, et al.
The Journal of Experimental Medicine|February 5, 2014
Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferonsEric M Pietras, Ranjani Lakshminarasimhan, Jose-Marc Techner, et al.
Blood Reviews|May 6, 2018
Current status and trends in the diagnostics of AML and MDSEvgenii Shumilov, Johanna Flach, Alexander Kohlmann, et al.
Nature|February 8, 2013
FOXO3A directs a protective autophagy program in haematopoietic stem cellsMatthew R Warr, Mikhail Binnewies, Johanna Flach, et al.
Critical Reviews in Oncology/Hematology|May 16, 2018
Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors: Diagnostic challenges in the era of high-throughput sequencing in hemato-oncologyEvgenii Shumilov, Johanna Flach, Thomas Pabst, et al.
Hematological Oncology|April 20, 2020
Clinical potential of introducing next-generation sequencing in patients at relapse of acute myeloid leukemiaJohanna Flach, Evgenii Shumilov, Gertrud Wiedemann, et al.
Blood Cancer Journal|November 14, 2018
Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine useUlrike Bacher, Evgenii Shumilov, Johanna Flach, et al.
Pageof 4